Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 Jan 2024
Historique:
received: 14 07 2023
accepted: 23 01 2024
medline: 26 1 2024
pubmed: 26 1 2024
entrez: 25 1 2024
Statut: epublish

Résumé

Ductular reactive (DR) cells exacerbate cholestatic liver injury and fibrosis. Herein, we posit that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) emanates from recruited macrophages and restrains DR cell expansion, thereby limiting cholestatic liver injury. Wild type (WT), Trail

Identifiants

pubmed: 38273071
doi: 10.1038/s41598-024-52710-3
pii: 10.1038/s41598-024-52710-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2145

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002379
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK124182
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Lazaridis, K. N. & LaRusso, N. F. Primary sclerosing cholangitis. N. Engl. J. Med. 375, 2501–2502. https://doi.org/10.1056/NEJMc1613273 (2016).
doi: 10.1056/NEJMc1613273 pubmed: 28002707
Banales, J. M. et al. Cholangiocyte pathobiology. Nat. Rev. Gastroenterol. Hepatol. 16, 269–281. https://doi.org/10.1038/s41575-019-0125-y (2019).
doi: 10.1038/s41575-019-0125-y pubmed: 30850822 pmcid: 6563606
Loarca, L. et al. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis. Lab. Investig. 97, 1385–1396. https://doi.org/10.1038/labinvest.2017.63 (2017).
doi: 10.1038/labinvest.2017.63 pubmed: 28892096
Sato, K. et al. Ductular reaction in liver diseases: Pathological mechanisms and translational significances. Hepatology 69, 420–430. https://doi.org/10.1002/hep.30150 (2019).
doi: 10.1002/hep.30150 pubmed: 30070383
Guicciardi, M. E., Trussoni, C. E., LaRusso, N. F. & Gores, G. J. The spectrum of reactive cholangiocytes in primary sclerosing cholangitis. Hepatology 71, 741–748. https://doi.org/10.1002/hep.31067 (2020).
doi: 10.1002/hep.31067 pubmed: 31833071
Gouw, A. S., Clouston, A. D. & Theise, N. D. Ductular reactions in human liver: Diversity at the interface. Hepatology 54, 1853–1863. https://doi.org/10.1002/hep.24613 (2011).
doi: 10.1002/hep.24613 pubmed: 21983984
Guicciardi, M. E. et al. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice. J. Hepatol. 69, 676–686. https://doi.org/10.1016/j.jhep.2018.05.018 (2018).
doi: 10.1016/j.jhep.2018.05.018 pubmed: 29802947 pmcid: 6098983
Duffield, J. S. et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Investig. 115, 56–65. https://doi.org/10.1172/JCI22675 (2005).
doi: 10.1172/JCI22675 pubmed: 15630444 pmcid: 539199
Stohr, D., Jeltsch, A. & Rehm, M. TRAIL receptor signaling: From the basics of canonical signal transduction toward its entanglement with ER stress and the unfolded protein response. Int. Rev. Cell. Mol. Biol. 351, 57–99. https://doi.org/10.1016/bs.ircmb.2020.02.002 (2020).
doi: 10.1016/bs.ircmb.2020.02.002 pubmed: 32247582
Tang, W. et al. TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent manner. Cell Res. 19, 758–767. https://doi.org/10.1038/cr.2009.57 (2009).
doi: 10.1038/cr.2009.57 pubmed: 19434100
Krishnan, A. et al. Tumor necrosis factor-related apoptosis-inducing ligand receptor deficiency promotes the ductular reaction, macrophage accumulation, and hepatic fibrosis in the Abcb4(-/-) Mouse. Am. J. Pathol. 190, 1284–1297. https://doi.org/10.1016/j.ajpath.2020.02.013 (2020).
doi: 10.1016/j.ajpath.2020.02.013 pubmed: 32240619 pmcid: 7280758
Dostert, C., Grusdat, M., Letellier, E. & Brenner, D. The TNF family of ligands and receptors: Communication modules in the immune system and beyond. Physiol. Rev. 99, 115–160. https://doi.org/10.1152/physrev.00045.2017 (2019).
doi: 10.1152/physrev.00045.2017 pubmed: 30354964
Wen, Y., Lambrecht, J., Ju, C. & Tacke, F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol. Immunol. 18, 45–56. https://doi.org/10.1038/s41423-020-00558-8 (2021).
doi: 10.1038/s41423-020-00558-8 pubmed: 33041338
Beattie, L. et al. Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions. J. Hepatol. 65, 758–768. https://doi.org/10.1016/j.jhep.2016.05.037 (2016).
doi: 10.1016/j.jhep.2016.05.037 pubmed: 27262757 pmcid: 5028381
Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512–518. https://doi.org/10.1038/s41586-019-1631-3 (2019).
doi: 10.1038/s41586-019-1631-3 pubmed: 31597160 pmcid: 6876711
Sanin, D. E. et al. A common framework of monocyte-derived macrophage activation. Sci. Immunol. 7, eabl7482. https://doi.org/10.1126/sciimmunol.abl7482 (2022).
doi: 10.1126/sciimmunol.abl7482 pubmed: 35427180
Jors, S. et al. Lineage fate of ductular reactions in liver injury and carcinogenesis. J. Clin. Investig. 125, 2445–2457. https://doi.org/10.1172/JCI78585 (2015).
doi: 10.1172/JCI78585 pubmed: 25915586 pmcid: 4497753
Dorrell, C. et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev. 25, 1193–1203. https://doi.org/10.1101/gad.2029411 (2011).
doi: 10.1101/gad.2029411 pubmed: 21632826 pmcid: 3110957
Guillot, A. et al. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression. Hepatology https://doi.org/10.1097/HEP.0000000000000270 (2023).
doi: 10.1097/HEP.0000000000000270 pubmed: 36630995
Azad, A. I. et al. Targeted apoptosis of ductular reactive cells reduces hepatic fibrosis in a mouse model of cholestasis. Hepatology 72, 1013–1028. https://doi.org/10.1002/hep.31211 (2020).
doi: 10.1002/hep.31211 pubmed: 32128842
Bruneau, A., Guillot, A. & Tacke, F. Macrophages in cholangiopathies. Curr. Opin. Gastroenterol. 38, 114–120. https://doi.org/10.1097/MOG.0000000000000814 (2022).
doi: 10.1097/MOG.0000000000000814 pubmed: 35098932
Wang, J. Neutrophils in tissue injury and repair. Cell Tissue Res. 371, 531–539. https://doi.org/10.1007/s00441-017-2785-7 (2018).
doi: 10.1007/s00441-017-2785-7 pubmed: 29383445 pmcid: 5820392
Arino, S. et al. Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease. J. Hepatol. https://doi.org/10.1016/j.jhep.2023.05.045 (2023).
doi: 10.1016/j.jhep.2023.05.045 pubmed: 37348790
Soehnlein, O. & Lindbom, L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10, 427–439. https://doi.org/10.1038/nri2779 (2010).
doi: 10.1038/nri2779 pubmed: 20498669
Metzemaekers, M., Gouwy, M. & Proost, P. Neutrophil chemoattractant receptors in health and disease: Double-edged swords. Cell Mol. Immunol. 17, 433–450. https://doi.org/10.1038/s41423-020-0412-0 (2020).
doi: 10.1038/s41423-020-0412-0 pubmed: 32238918 pmcid: 7192912
Cartland, S. P. et al. TRAIL-expressing monocyte/macrophages are critical for reducing inflammation and atherosclerosis. iScience 12, 41–52. https://doi.org/10.1016/j.isci.2018.12.037 (2019).
doi: 10.1016/j.isci.2018.12.037 pubmed: 30665196 pmcid: 6348195
Labiano, I. et al. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation. J. Hepatol. 77, 991–1004. https://doi.org/10.1016/j.jhep.2022.05.044 (2022).
doi: 10.1016/j.jhep.2022.05.044 pubmed: 35750136
Malhi, H. et al. C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis. J. Biol. Chem. 288, 18624–18642. https://doi.org/10.1074/jbc.M112.442954 (2013).
doi: 10.1074/jbc.M112.442954 pubmed: 23720735 pmcid: 3696637
Chen, H. et al. Cytofkit: A bioconductor package for an integrated mass cytometry data analysis pipeline. PLoS Comput. Biol. 12, e1005112. https://doi.org/10.1371/journal.pcbi.1005112 (2016).
doi: 10.1371/journal.pcbi.1005112 pubmed: 27662185 pmcid: 5035035
Becher, B. et al. High-dimensional analysis of the murine myeloid cell system. Nat. Immunol. 15, 1181–1189. https://doi.org/10.1038/ni.3006 (2014).
doi: 10.1038/ni.3006 pubmed: 25306126
Metsalu, T. & Vilo, J. ClustVis: A web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 43, W566-570. https://doi.org/10.1093/nar/gkv468 (2015).
doi: 10.1093/nar/gkv468 pubmed: 25969447 pmcid: 4489295

Auteurs

Anuradha Krishnan (A)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Nazli Begum Ozturk (NB)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Kaiyel A Cutshaw (KA)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Maria Eugenia Guicciardi (ME)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Takashi Kitagataya (T)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Kirsta E Olson (KE)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Kevin D Pavelko (KD)

Department of Immunology, Mayo Clinic, Rochester, MN, USA.

William Sherman (W)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Alexander Q Wixom (AQ)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Nidhi Jalan-Sakrikar (N)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Michelle Baez-Faria (M)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Florencia Gutierrez (F)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Gregory J Gores (GJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. gores.gregory@mayo.edu.

Classifications MeSH